Ranolazine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00243 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 45 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 2 | rheumatoid arthritis | KG + DL |
| 3 | brachydactyly-syndactyly syndrome | KG + DL |
| 4 | myositis fibrosa | KG + DL |
| 5 | idiopathic granulomatous myositis | KG + DL |
| 6 | tendinitis | KG + DL |
| 7 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 8 | fibromyalgia | KG + DL |
| 9 | headache disorder | KG + DL |
| 10 | conjunctivitis | KG + DL |
| 11 | gout | KG + DL |
| 12 | nephrogenic diabetes insipidus | KG + DL |
| 13 | trigeminal autonomic cephalalgia | KG + DL |
| 14 | duodenal obstruction | KG + DL |
| 15 | pulmonary hypertension | KG + DL |
| 16 | gastrin secretion abnormality | KG + DL |
| 17 | bronchitis | KG + DL |
| 18 | duodenal ulcer (disease) | KG + DL |
| 19 | inclusion body myositis | KG + DL |
| 20 | kyphoscoliotic heart disease | KG + DL |
| 21 | duodenogastric reflux | KG + DL |
| 22 | Tourette syndrome | KG + DL |
| 23 | multiple endocrine neoplasia | KG + DL |
| 24 | diabetes insipidus, nephrogenic, X-linked | KG + DL |
| 25 | nephrogenic diabetes insipidus-intracranial calcification syndrome | KG + DL |
| 26 | common cold | KG + DL |
| 27 | paratenonitis | KG + DL |
| 28 | calcific tendinitis | KG + DL |
| 29 | Smouldering systemic mastocytosis | KG + DL |
| 30 | myositis | KG + DL |
| 31 | Plasmodium falciparum malaria | KG + DL |
| 32 | female breast carcinoma | KG + DL |
| 33 | trichotillomania | KG + DL |
| 34 | lymphoadenopathic mastocytosis with eosinophilia | KG + DL |
| 35 | systemic mastocytosis | KG + DL |
| 36 | acute contagious conjunctivitis | KG + DL |
| 37 | subarachnoid hemorrhage (disease) | KG + DL |
| 38 | conjunctivitis (disease) | KG + DL |
| 39 | abnormality of glucagon secretion | KG + DL |
| 40 | obsolete familial combined hyperlipidemia | KG + DL |
| 41 | peripheral vascular disease | KG + DL |
| 42 | vestibular neuronitis | KG + DL |
| 43 | amebic dysentery | KG + DL |
| 44 | pneumocystosis | KG + DL |
| 45 | motor nerve neuritis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.